MEDS TRxADE HEALTH, Inc.: שווי הפעילות העסקית
TRxADE HEALTH, Inc. (MEDS) is implementing software robots for predictive drug ordering and automated price analysis. Business revenues are based on commissions from independent pharmacy purchases made via the TRxADE marketplace. The price action for the company shown on this chart, where the Enterprise Value is 39.59, confirms the model's resilience: the deep integration of IT tools into client finances creates a virtually continuous payment stream.
פילוחים אנליטיים של חברת TRxADE HEALTH, Inc.
Amidst the radical transformation of the TRxADE HEALTH (MEDS) logistics model, the aggregate enterprise value allows investors to filter out the volatility of current financial results. This indicator determines the actual acquisition cost of the asset by summing market capitalization with debt obligations and subtracting available cash, providing the investor with an objective view of the company's scale regardless of its borrowing structure.